Cargando…

Real-life evaluation of histologic scores for Ulcerative Colitis in remission

BACKGROUND: Histological evaluation of ulcerative colitis (UC) patients has been debated ever since the first description of the disease and its role in follow-up has never been fully established. Recent evidence suggests an added benefit in accuracy when evaluating if the patient is in remission. U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arkteg, Christian Børde, Wergeland Sørbye, Sveinung, Buhl Riis, Lene, Dalen, Stig Manfred, Florholmen, Jon, Goll, Rasmus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939352/ https://www.ncbi.nlm.nih.gov/pubmed/33684168 http://dx.doi.org/10.1371/journal.pone.0248224

Ejemplares similares

Ulcerative colitis: functional analysis of the in-depth proteome
por: Schniers, Armin, et al.
Publicado: (2019)

Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2019)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2016)

Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
por: Johnsen, Kay-Martin, et al.
Publicado: (2022)

Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
por: Florholmen, Jon R., et al.
Publicado: (2020)

Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?
por: Cui, Guanglin, et al.
Publicado: (2022)

Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
por: Goll, Rasmus, et al.
Publicado: (2019)

A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression
por: Diab, Joseph, et al.
Publicado: (2019)

Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure
por: Nestegard, Oddmund, et al.
Publicado: (2022)

Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis
por: Diab, Joseph, et al.
Publicado: (2019)

Hypo-osmotic stress induces the epithelial alarmin IL-33 in the colonic barrier of ulcerative colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2022)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Population-based screening for celiac disease reveals that the majority of patients are undiagnosed and improve on a gluten-free diet
por: Kvamme, Jan-Magnus, et al.
Publicado: (2022)

Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication
por: Nestegard, Oddmund, et al.
Publicado: (2020)

Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
por: Narang, Vikram, et al.
Publicado: (2018)

May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
por: Skjeldestad, Finn Egil, et al.
Publicado: (2023)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
por: Steinsbø, Øyvind, et al.
Publicado: (2022)

Transcriptomic Landscape of Treatment—Naïve Ulcerative Colitis
por: Taman, Hagar, et al.
Publicado: (2018)

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans
por: Seidelin, Jakob Benedict, et al.
Publicado: (2021)

Evaluation of absolute quantitation by nonlinear regression in probe-based real-time PCR
por: Goll, Rasmus, et al.
Publicado: (2006)

Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
por: George, Lauren A, et al.
Publicado: (2023)

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2022)

Histological evaluation in ulcerative colitis
por: DeRoche, Tom C., et al.
Publicado: (2014)

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
por: Iacucci, Marietta, et al.
Publicado: (2021)

Sa078 CLINICAL AND LABORATORY MARKERS DO NOT PREDICT DEEP HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS
por: Sharma, Disha, et al.
Publicado: (2021)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Genome-wide DNA Methylation in Treatment-naïve Ulcerative Colitis
por: Taman, Hagar, et al.
Publicado: (2018)

DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis
por: Taman, Hagar, et al.
Publicado: (2021)

ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis
por: Cui, Guanglin, et al.
Publicado: (2020)

Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
por: Cui, Guanglin, et al.
Publicado: (2021)

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)

A167 HISTOLOGICAL REMISSION PLACEBO RATES IN ULCERATIVE COLITIS TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Youssef, M, et al.
Publicado: (2023)

Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis
por: Rath, Timo, et al.
Publicado: (2023)

Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study
por: Shah, Jimil, et al.
Publicado: (2019)

Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn’s disease from ulcerative colitis
por: James, Jaslin Pallikkunnath, et al.
Publicado: (2023)

Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis
por: Meng, Wei, et al.
Publicado: (2023)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b24oqn05hqlmpcs15946ceo97q